Neal A. Halsey, MD, the
Director of the Institute for Vaccine Safety, is a Professor
in the Department of International Health at the Johns
Hopkins Bloomberg School of Public Health and in the
Department of Pediatrics in the School of Medicine. Dr.
Halsey completed undergraduate and medical training at the
University of Wisconsin, pediatrics and infectious diseases
training at the University of Colorado, and he served in the
Epidemic Intelligence Service at the Centers for Disease
Control and Prevention(CDC) in Atlanta. After 5 years as a
faculty member at Tulane University he has been at Johns
Hopkins University since 1985.
Dr. Halsey has authored more than 240 peer reviewed publications and 41 book chapters on the prevention and treatment of infectious diseases through vaccination, and participated in the development of more than 100 guidelines for the use of vaccines while serving on advisory groups for the WHO Expanded Programme on Immunization, the Advisory Committee for Immunization Practices (ACIP) for CDC, and the American Academy of Pediatrics Committee on Infectious Diseases.
Dr Halsey has focused his research and teaching in recent years on vaccine safety. He is the Principal Investigator of the CDC funded Clinical Immunization Safety Assessment program and the at the Johns Hopkins Bloomberg School of Public Health.
updated April 2017
Moulton, PhD, the Co-Director of IVS, is a
biostatistician who focuses on issues of vaccine safety and
effectiveness. He has made applied and theoretical
contributions to the design and analysis of Phase II, III,
and IV vaccine investigations. Dr. Moulton's areas of
expertise include statistical epidemiology and cluster
updated April 2017
Daniel A. Salmon, PhD, the Deputy Director of IVS, has training, research and practice interests in epidemiology and health policy. He has focused on post-licensure vaccine safety and the factors associated with parental decisions to vaccinate, or not vaccinate, their children. Dr. Salmon served as the Director of Vaccine Safety at the National Vaccine Program Office, where he was responsible for coordinating federal vaccine safety activities. Dr. Salmon has conducted a broad range of studies examining the safety of vaccines, the rates of vaccine refusal, the reasons why parents refuse vaccines, the impact of health care providers and local and state policies on vaccine refusal and the individual and community risks of unvaccinated children. Dr. Salmon is widely published in the medical literature.
updated Sept 2012
Kawsar R. Talaat,
IVS Deputy Director, Clinical Research, is a physician, who
is board certified in Internal Medicine, Pediatrics and
Infectious Diseases. Her research interests are vaccine
clinical trials as well as challenge studies. She has
extensive experience in the design and conduct of Phase 1
and 2 clinical vaccine trials for new vaccines, and in the
conduct of challenge studies. In addition to her work on
novel vaccines, Dr. Talaat is interested in the safety of
existing vaccines. She has been working with the Institute
for Vaccine Safety for several years. A member of the CDC
Clinical Immunization Safety Assessment group and clinical
Deputy Director for the Institute for Vaccine safety, Dr.
Talaat has served on several working groups looking at
vaccine safety and has co-authored a WHO-sponsored
systematic review of the safety of influenza vaccines in
updated Nov 2016